Every lab software vendor in 2026 says they have AI. Most of them mean a chat box bolted on the side. Here's how to tell the difference between a real AI feature and a marketing claim, and where AI actually helps in a diagnostic lab.
Where AI genuinely helps
Trend detection across visits
The simplest, highest-leverage use case. A patient has had HbA1c measured every quarter for two years. The AI surfaces the trend — improving, stable, deteriorating — and the rate of change. The pathologist doesn't have to scroll through history. The report includes a chart the patient can take to their physician.
Critical-value triage
When a critical value comes through, AI can prioritize the notification queue: most-likely-to-need-immediate-attention first, based on the combination of values and the patient's history. The technologist still calls. The AI just orders the queue.
QC pattern detection
Levey-Jennings charts tell you when QC is out. AI tells you when QC is drifting — slowly trending in a direction that will fail in three days. That's the difference between an unscheduled calibration and a scheduled one.
Report drafting assistance
For tests with structured inputs (e.g. calculated panels, lipid profiles, anemia workups), AI can draft the interpretation paragraph from the values. The pathologist edits and approves. The two-step approval is preserved.
Where AI is mostly hype
Replacing the pathologist
AI cannot replace the pathologist. Period. It can help them — drafting, trend calls, QC patterns — but a diagnostic decision is a clinical decision, and the pathologist owns it. Any vendor that says otherwise is selling.
Reading blood smears or histopathology
Computer vision models exist, but they're narrow: trained on specific cell types, specific organs, specific stains. They help — but they don't replace a trained pathologist looking at a slide. And the regulatory bar for clinical-grade models is high.
Auto-approving results
AI should never auto-approve. Two-step approval exists for a reason: it's the PHC-required control that protects the patient and the pathologist. AI can draft, suggest, prioritize — but the human sign-off is the system.
How to evaluate an "AI" feature in a lab software vendor
- What does it actually do? A specific, named task — trend detection, QC drift, draft interpretation — not "AI-powered insights."
- Can the human override it? If the answer is no, walk away.
- Does it learn from your data? Or is it a static model? Both are fine, but you should know.
- Is there an audit trail? When AI drafts something, the pathologist who edited it should be recorded. When AI prioritizes a queue, the reason should be logged.
- What data leaves your environment? For cloud-deployed AI, you should know whether the inference happens on your data in your tenant, or in a shared model.
How xMed ships AI
xMed's built-in AI does four things, and nothing else:
- Trend detection across visits (HbA1c, lipids, tumor markers, etc.)
- Critical-value triage and queue ordering
- QC drift detection
- Draft interpretation for structured panels
Every output is editable. The pathologist's sign-off is preserved. The audit log captures what the AI suggested and what the human changed. We don't auto-approve anything.
Related: Choosing an LIS in Pakistan · PHC-compliant healthcare software
